STOKE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD AGREEMENTScientific Advisory Board Agreement • August 8th, 2022 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 8th, 2022 Company Industry JurisdictionThis SCIENTIFIC ADVISORY BOARD Agreement (this “Agreement”) is entered into as of June 1, 2022 (the “Effective Date”) between Stoke Therapeutics, Inc., a Delaware corporation having offices at 45 Wiggins Avenue, Bedford, MA 01730 (“Stoke”) and Adrian Krainer, Ph.D. (“Advisor”). Advisor has unique skills and knowledge pertinent to Stoke’s business and Stoke desires to retain Advisor as a member of Stoke’s Scientific Advisory Board (“SAB”) under the terms of this Agreement.
STOKE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD AGREEMENTScientific Advisory Board Agreement • August 10th, 2020 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThis SCIENTIFIC ADVISORY BOARD Agreement (this “Agreement”) is entered into as of June 1, 2020 (the “Effective Date”) between Stoke Therapeutics, Inc., a Delaware corporation having offices at 45 Wiggins Avenue, Bedford, MA 01730 (“Stoke”) and Adrian Krainer, Ph.D. (“Advisor”). Advisor has unique skills and knowledge pertinent to Stoke’s business and Stoke desires to retain Advisor as a member of Stoke’s Scientific Advisory Board (“SAB”) under the terms of this Agreement.